{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:24:28Z","timestamp":1790162668053,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.humpath.2018.05.006","type":"journal-article","created":{"date-parts":[[2018,5,12]],"date-time":"2018-05-12T02:44:51Z","timestamp":1526093091000},"page":"109-115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Hepatic micrometastases are associated with poor prognosis in patients with liver metastases from neuroendocrine tumors of the digestive tract"],"prefix":"10.1016","volume":"79","author":[{"given":"William E.","family":"Gibson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raul S.","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin M.M.","family":"Cates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chanjuan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2018.05.006_bb0005","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","article-title":"One hundred years after \u201ccarcinoid\u201d: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States","volume":"26","author":"Yao","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2018.05.006_bb0010","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/cncr.11105","article-title":"A 5-decade analysis of 13,715 carcinoid tumors","volume":"97","author":"Modlin","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2018.05.006_bb0015","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.critrevonc.2016.03.013","article-title":"Pancreatic neuroendocrine tumors: challenges in an underestimated disease","volume":"101","author":"Viudez","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.humpath.2018.05.006_bb0020","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1093\/annonc\/mdt377","article-title":"Gastrointestinal carcinoid: epidemiological and survival evidence from a large population-based study (n = 25 531)","volume":"24","author":"Mocellin","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.humpath.2018.05.006_bb0025","doi-asserted-by":"crossref","first-page":"24950","DOI":"10.18632\/oncotarget.7436","article-title":"A new immunohistochemistry prognostic score (IPS) for recurrence and survival in resected pancreatic neuroendocrine tumors (PanNET)","volume":"7","author":"Viudez","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.humpath.2018.05.006_bb0030","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S1470-2045(15)70136-1","article-title":"Pazopanib and depot octreotide in advanced, well-differentiated neuroendocrine tumours: a multicentre, single-group, phase 2 study","volume":"16","author":"Phan","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.humpath.2018.05.006_bb0035","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1111\/j.1572-0241.2007.01185.x","article-title":"A three-decade analysis of 3,911 small intestinal neuroendocrine tumors: the rapid pace of no progress","volume":"102","author":"Modlin","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.humpath.2018.05.006_bb0040","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.bpg.2013.01.006","article-title":"Epidemiology of gastroenteropancreatic neuroendocrine tumours","volume":"26","author":"Fraenkel","year":"2012","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.humpath.2018.05.006_bb0045","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1200\/JCO.2012.44.5924","article-title":"Prognostic validity of the American Joint Committee on Cancer Staging classification for midgut neuroendocrine tumors","volume":"31","author":"Strosberg","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2018.05.006_bb0050","doi-asserted-by":"crossref","first-page":"xiii","DOI":"10.1016\/j.hoc.2015.09.012","article-title":"Neuroendocrine tumors--current and future clinical advances","volume":"30","author":"Chan","year":"2016","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.humpath.2018.05.006_bb0055","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.soc.2015.08.010","article-title":"Treatment of neuroendocrine liver metastases","volume":"25","author":"Farley","year":"2016","journal-title":"Surg Oncol Clin N Am"},{"key":"10.1016\/j.humpath.2018.05.006_bb0060","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1002\/cncr.28760","article-title":"Therapeutic strategies for neuroendocrine liver metastases","volume":"121","author":"Frilling","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2018.05.006_bb0065","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s11523-012-0219-8","article-title":"Liver-directed therapies in liver metastases from neuroendocrine tumors of the gastrointestinal tract","volume":"7","author":"Zappa","year":"2012","journal-title":"Target Oncol"},{"key":"10.1016\/j.humpath.2018.05.006_bb0070","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1136\/gut.2009.204453","article-title":"Therapeutic strategies for advanced neuroendocrine carcinomas of jejunum\/ileum and pancreatic origin","volume":"60","author":"Auernhammer","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.humpath.2018.05.006_bb0075","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1586\/egh.11.60","article-title":"Treatment options for unresectable neuroendocrine liver metastases","volume":"6","author":"John","year":"2012","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.humpath.2018.05.006_bb0080","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/modpathol.2013.232","article-title":"Should mesenteric tumor deposits be included in staging of well-differentiated small intestine neuroendocrine tumors?","volume":"27","author":"Gonzalez","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2018.05.006_bb0085","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/PAS.0000000000000751","article-title":"Mesenteric tumor deposits in midgut small intestinal neuroendocrine tumors are a stronger indicator than lymph node metastasis for liver metastasis and poor prognosis","volume":"41","author":"Fata","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2018.05.006_bb0090","series-title":"AJCC Cancer Staging Manual","year":"2017"},{"key":"10.1016\/j.humpath.2018.05.006_bb0095","series-title":"WHO Classification of Tumours of the Digestive System","year":"2010"},{"key":"10.1016\/j.humpath.2018.05.006_bb0100","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/SLA.0b013e3181bdf8cf","article-title":"Hepatic metastases from neuroendocrine tumors with a \u201cthin slice\u201d pathological examination: they are many more than you think","volume":"251","author":"Elias","year":"2010","journal-title":"Ann Surg"},{"key":"10.1016\/j.humpath.2018.05.006_bb0105","doi-asserted-by":"crossref","first-page":"146590","DOI":"10.1155\/2012\/146590","article-title":"Surgical treatment of neuroendocrine liver metastases","volume":"2012","author":"Lee","year":"2012","journal-title":"Int J Hepatol"},{"key":"10.1016\/j.humpath.2018.05.006_bb0110","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000443167","article-title":"ENETS consensus guidelines update for the management of distant metastatic disease of intestinal, pancreatic, bronchial neuroendocrine neoplasms (NEN) and NEN of unknown primary site","volume":"103","author":"Pavel","year":"2016","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.humpath.2018.05.006_bb0115","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1097\/PAS.0b013e318293ddf1","article-title":"Intrabiliary growth of liver metastases: clinicopathologic features, prevalence, and outcome","volume":"37","author":"Estrella","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2018.05.006_bb0120","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s00428-017-2093-3","article-title":"In liver metastases from small intestinal neuroendocrine tumors, SSTR2A expression is heterogeneous","volume":"470","author":"Charoenpitakchai","year":"2017","journal-title":"Virchows Arch"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817718301643?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817718301643?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T19:01:40Z","timestamp":1536346900000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817718301643"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":24,"alternative-id":["S0046817718301643"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2018.05.006","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatic micrometastases are associated with poor prognosis in patients with liver metastases from neuroendocrine tumors of the digestive tract","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2018.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}